Johannes Schulte-Pelkum
Johannes Schulte-Pelkum publishes mostly in Infectious Diseases, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Systemic Sclerosis and Related Diseases and Inflammatory Myopathies and Dermatomyositis.
- World rank
- #3,400,889 of 7,710,434 ranked researchers
- Rank in Germany
- #169,736 of 364,343
- Works
- 22
- Citations
- 582
- Citations per work
- 26.5
What does Johannes Schulte-Pelkum research?
Johannes Schulte-Pelkum's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1256.5%
- Medicine1256.5%
- Everything else835.4%
- Life Sciences28.1%
- 1Infectious Diseases14% of their works
- 2Pathology and Forensic Medicine13% of their works
- 3Radiology, Nuclear Medicine and Imaging11% of their works
- 4Rheumatology10% of their works
- 5Molecular Biology8% of their works
- 6Epidemiology8% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Systemic Sclerosis and Related Diseases
- Inflammatory Myopathies and Dermatomyositis
- Systemic Lupus Erythematosus Research
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Diabetes and associated disorders
- Advanced Biosensing Techniques and Applications
Which keywords describe Johannes Schulte-Pelkum's research?
The keywords of their largest research topics: Autoantibodies, Treatment, ACE2 Receptor, Fc Receptors, SARS-CoV-2, Therapeutic Antibodies, Fibrosis and Systemic Sclerosis.
- Protein Microarrays
- Genetics
- Clinical Characteristics
- Coronavirus
- Inflammatory Myopathies
- Dermatomyositis
- Systemic Sclerosis
- Therapeutic Antibodies
- Fc Receptors
- Treatment
- Autoantibodies
- ACE2 Receptor
- SARS-CoV-2
- Fibrosis
- Antiphospholipid Syndrome
- Epidemiology
- Systemic Lupus Erythematosus
- Vaccine
- Thrombosis
- High-Throughput Analysis
- Type 1 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Autoantibodies163 topics
- Treatment112 topics
- ACE2 Receptor72 topics
- Fc Receptors71 topic
- SARS-CoV-272 topics
- Therapeutic Antibodies71 topic
- Fibrosis61 topic
- Systemic Sclerosis61 topic
- Antiphospholipid Syndrome51 topic
- Dermatomyositis51 topic
- Epidemiology52 topics
- Inflammatory Myopathies51 topic
- Systemic Lupus Erythematosus51 topic
- Coronavirus41 topic
- Vaccine41 topic
- Clinical Characteristics31 topic
- Thrombosis31 topic
- Genetics21 topic
- High-Throughput Analysis21 topic
- Protein Microarrays21 topic
- Type 1 Diabetes21 topic
Where does Johannes Schulte-Pelkum work?
Johannes Schulte-Pelkum's main affiliation in the publication record is Protagen (Germany), Germany.
How many publications and citations does Johannes Schulte-Pelkum have?
OpenAlex counts 22 works and 582 citations for Johannes Schulte-Pelkum, an h-index of 9, ranking #3,400,889 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Johannes Schulte-Pelkum. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.